|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-5-15
|
|
pubmed:abstractText |
Pharmacogenetics of tardive dyskinesia and dopamine D3 (DRD3), serotonin 2A (HTR2A), and 2C (HTR2C) receptors has been examined in various populations, but not in Russians.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chlorpromazine,
http://linkedlifedata.com/resource/pubmed/chemical/Cystine,
http://linkedlifedata.com/resource/pubmed/chemical/DRD3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Glycine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2A,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2C,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D3,
http://linkedlifedata.com/resource/pubmed/chemical/Serine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0278-5846
|
|
pubmed:author |
pubmed-author:Al HadithyA F YAF,
pubmed-author:BrouwersJ R B JJR,
pubmed-author:BruggemanRR,
pubmed-author:FedorenkoOO,
pubmed-author:IvanovaS ASA,
pubmed-author:KornetovaEE,
pubmed-author:LoonenA J MAJ,
pubmed-author:PechlivanoglouPP,
pubmed-author:RyadovayaLL,
pubmed-author:SemkeAA,
pubmed-author:WilffertBB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
30
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
475-81
|
|
pubmed:meshHeading |
pubmed-meshheading:19439249-Adult,
pubmed-meshheading:19439249-Aged,
pubmed-meshheading:19439249-Akathisia, Drug-Induced,
pubmed-meshheading:19439249-Chlorpromazine,
pubmed-meshheading:19439249-Cross-Sectional Studies,
pubmed-meshheading:19439249-Cystine,
pubmed-meshheading:19439249-Disability Evaluation,
pubmed-meshheading:19439249-Extremities,
pubmed-meshheading:19439249-Face,
pubmed-meshheading:19439249-Female,
pubmed-meshheading:19439249-Gene Frequency,
pubmed-meshheading:19439249-Genotype,
pubmed-meshheading:19439249-Glycine,
pubmed-meshheading:19439249-Humans,
pubmed-meshheading:19439249-Male,
pubmed-meshheading:19439249-Middle Aged,
pubmed-meshheading:19439249-Models, Statistical,
pubmed-meshheading:19439249-Mouth,
pubmed-meshheading:19439249-Pharmacogenetics,
pubmed-meshheading:19439249-Polymorphism, Genetic,
pubmed-meshheading:19439249-Psychiatric Status Rating Scales,
pubmed-meshheading:19439249-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:19439249-Receptor, Serotonin, 5-HT2C,
pubmed-meshheading:19439249-Receptors, Dopamine D3,
pubmed-meshheading:19439249-Schizophrenia,
pubmed-meshheading:19439249-Serine,
pubmed-meshheading:19439249-Severity of Illness Index,
pubmed-meshheading:19439249-Siberia
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
|
|
pubmed:affiliation |
Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands. a.f.y.al.hadithy@rug.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
